ArticleWorld journal of urology2019

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.

Bert Dhondt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.